Ascletis Announces First Participants Dosed in U.S. Phase I Clinical Study of ASC50, a Potential Best-in-Class Oral Small Molecu

Posted Jun 18 by Two Blokes

-  T he Phase I trial evaluates the safety, tolerability and preliminary efficacy of ASC50 for the treatment o

Source: Two Blokes Trading

UPDATED: Serina Therapeutics Congratulates Juvenescence Ltd. on $76M First Tranche Close of Series B Funding and Strategic Partn

Posted Jun 18 by Two Blokes

HUNTSVILLE, June 17, 2025 (GLOBE NEWSWIRE) -- This press release has been updated to reflect the correct timin

Source: Two Blokes Trading

PACIRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Pacira BioSciences, Inc. on Behalf of Long-Term Stockholders and Enco

Posted Jun 18 by Two Blokes

NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder r

Source: Two Blokes Trading

FMC ALERT: Bragar Eagel & Squire, P.C. is Investigating FMC Corporation on Behalf of Long-Term Stockholders and Encourages Inves

Posted Jun 18 by Two Blokes

NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder r

Source: Two Blokes Trading

PROFICIENT AUTO ALERT: Bragar Eagel & Squire, P.C. is Investigating Proficient Auto Logistics, Inc. on Behalf of Proficient Auto

Posted Jun 18 by Two Blokes

NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder r

Source: Two Blokes Trading

GENEDX ALERT: Bragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. on Behalf of GeneDx Stockholders and Encourages

Posted Jun 18 by Two Blokes

NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder r

Source: Two Blokes Trading

Sam Altman says Meta offered $100 million bonuses to OpenAI employees

Posted Jun 18 by Two Blokes

OpenAI CEO Sam Altman said that Meta has offered his employees bonuses of $100 million to recruit them, as the

Source: Two Blokes Trading

Acurx Pharmaceuticals, Inc. Announces Exercise of Warrants for $2.67 Million Gross Proceeds

Posted Jun 18 by Two Blokes

STATEN ISLAND, N.Y. , June 17, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the

Source: Two Blokes Trading

Beyond Air, Inc. (XAIR) Q4 2025 Earnings Call Transcript

Posted Jun 18 by Two Blokes

Beyond Air, Inc. (NASDAQ:XAIR ) Q4 2025 Earnings Conference Call June 17, 2025 4:30 PM ET Company Participants

Source: Two Blokes Trading

WuXi AppTec Earns SBTi Validation for Near-Term Emissions Reduction Targets

Posted Jun 18 by Two Blokes

SHANGHAI , June 17, 2025 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D

Source: Two Blokes Trading

Ascletis Announces First Participants Dosed in U.S. Phase I Clinical Study of ASC50, a Potential Best-in-Class Oral Small Molecu

Posted Jun 18 by Two Blokes

-  T he Phase I trial evaluates the safety, tolerability and preliminary efficacy of ASC50 for the treatment o

Source: Two Blokes Trading

UPDATED: Serina Therapeutics Congratulates Juvenescence Ltd. on $76M First Tranche Close of Series B Funding and Strategic Partn

Posted Jun 18 by Two Blokes

HUNTSVILLE, June 17, 2025 (GLOBE NEWSWIRE) -- This press release has been updated to reflect the correct timin

Source: Two Blokes Trading